Figure 2From: Investigation of ejaculatory disorder by silodosin in the treatment of prostatic hyperplasia Incidence of ejaculatory disorder in all patients and sexually active patients. Ejaculatory disorder present (fully shaded area). ejaculatory disorder absent (non shaded area).Back to article page